About Careers Internship MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Review Finds New Biologic Drug to be Effective in Rheumatoid Arthritis

by Rajashri on October 9, 2009 at 9:20 PM
Font : A-A+

 Review Finds New Biologic Drug to be Effective in Rheumatoid Arthritis

A new Cochrane Systematic Review has found that Abatacept, a member of a new class of drug that targets immune cells to treat rheumatoid arthritis (RA), is effective in the condition. The review examines recent trials to assess safety and efficacy of the drug.

RA is an autoimmune disease affecting up to 1 in 100 people in Western countries. RA patients experience chronic pain and inflammation as a result of the body's own immune system attacking the lining of the joints. Abatacept is a new "biologic" drug that works by blocking the actions of the immune cells, called T cells, which cause joint inflammation.

Advertisement

The review combined data from seven trials including 2,908 patients, whose symptoms were assessed after one year of taking the drug or a placebo. Compared to placebo, patients given abatacept were twice as likely to achieve a 50% improvement in symptoms, including pain and the number of tender and swollen joints. Patients who took the drug also experienced improvements in physical ability. There was no progression in damage to joints of people who took abatacept at 12 months follow up. However, serious adverse effects increased if the drug was given in combination with other biologics.

"Like other biologics, abatacept is an expensive drug, but if the benefits are evident, it may be of great interest to patients with rheumatoid arthritis who fail standard therapy or other biologic treatment. Our review shows that it is indeed effective, and generally well-tolerated, but we would strongly recommend that it is not used with other biologics," says lead researcher, Lara Maxwell, of the Institute of Population Health at the University of Ottawa in Ontario, Canada.
Advertisement

"There is a need for more long term studies to determine whether the drug is safe and the effect sustained over longer periods. Better designed studies in the future are likely to have a longer follow-up and high retention rates, and it would be useful to conduct trials of one biologic versus another."



Source: Eurekalert
RAS
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
H1N1 Influenza Prevention in Children: What Parents Need to Know
Dietary Factors Responsible for Dihydrotestosterone (DHT) Production and Hair Loss
Test Your Knowledge About Chromosomes?
View all
Recommended Reading
News Archive
Date
Category
Advertisement
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Drug Toxicity Rheumatoid Arthritis Oligoarthritis Chemotherapy Signature Drug Toxicity Knee Replacement Arthritis 

Most Popular on Medindia

Loram (2 mg) (Lorazepam) Sanatogen Accident and Trauma Care Post-Nasal Drip Vent Forte (Theophylline) Drug Interaction Checker Drug - Food Interactions Blood - Sugar Chart Blood Pressure Calculator Daily Calorie Requirements
This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
×

Review Finds New Biologic Drug to be Effective in Rheumatoid Arthritis Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests